IDEAYA Biosciences (FRA:30J) Receivables Turnover : 0.00 (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is IDEAYA Biosciences Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. IDEAYA Biosciences's Revenue for the three months ended in Mar. 2025 was €0.00 Mil. IDEAYA Biosciences's average Accounts Receivable for the three months ended in Mar. 2025 was €0.00 Mil.

IDEAYA Biosciences Receivables Turnover Historical Data

The historical data trend for IDEAYA Biosciences's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEAYA Biosciences Receivables Turnover Chart

IDEAYA Biosciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Receivables Turnover

Get a 7-Day Free Trial

10.41

19.63

81.84

198.56

668.50

IDEAYA Biosciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	636.67	-

Competitive Comparison of IDEAYA Biosciences's Receivables Turnover

For the Biotechnology subindustry, IDEAYA Biosciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDEAYA Biosciences's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IDEAYA Biosciences's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where IDEAYA Biosciences's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

IDEAYA Biosciences Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

IDEAYA Biosciences's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

	Receivables Turnover (A: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2024 )	/ (	(Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )
=	6.685	/ (	(0.017	+	0.003)	/	2 )
=	6.685	/	0.01
=	668.50

IDEAYA Biosciences's Receivables Turnover for the quarter that ended in Mar. 2025 is calculated as

	Receivables Turnover (Q: Mar. 2025 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2025 )	/ (	(Accounts Receivable (Q: Dec. 2024 )	+	Accounts Receivable (Q: Mar. 2025 ))	/	count )
=	0	/ (	(0.003	+	0)	/	1 )
=	0	/	0.003
=	N/A

IDEAYA Biosciences (FRA:30J) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

IDEAYA Biosciences Receivables Turnover Related Terms

Thank you for viewing the detailed overview of IDEAYA Biosciences's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEAYA Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IDEAYA Biosciences Inc (FRA:30J) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

IDYA:USA

Address

5000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080

Website

https://www.ideayabio.com

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

IDEAYA Biosciences Headlines

No Headlines